Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Keros Therapeutics (KROS) Interest Coverage Ratio (2019 - 2022)

Keros Therapeutics (KROS) has disclosed Interest Coverage Ratio for 4 consecutive years, with 24126.0 as the latest value for Q1 2022.

  • For the quarter ending Q1 2022, Interest Coverage Ratio fell 53.0% year-over-year to 24126.0, compared with a TTM value of 114790.0 through Dec 2022, down 714.5%, and an annual FY2022 reading of 114790.0, down 714.5% over the prior year.
  • Interest Coverage Ratio was 24126.0 for Q1 2022 at Keros Therapeutics, down from 4866.0 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 775.33 in Q3 2019 and bottomed at 24126.0 in Q1 2022.
  • Average Interest Coverage Ratio over 4 years is 9954.99, with a median of 8444.0 recorded in 2020.
  • The sharpest move saw Interest Coverage Ratio tumbled 723.39% in 2020, then soared 63.39% in 2021.
  • Year by year, Interest Coverage Ratio stood at 775.33 in 2019, then crashed by 1614.23% to 13291.0 in 2020, then skyrocketed by 63.39% to 4866.0 in 2021, then plummeted by 395.81% to 24126.0 in 2022.
  • Business Quant data shows Interest Coverage Ratio for KROS at 24126.0 in Q1 2022, 4866.0 in Q4 2021, and 20197.0 in Q3 2021.